Cargando…
The Use of Functional Genomics in Conjunction with Metabolomics for Mycobacterium tuberculosis Research
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a fatal infectious disease, resulting in 1.4 million deaths globally per annum. Over the past three decades, genomic studies have been conducted in an attempt to elucidate the functionality of the genome of the pathogen. However, many aspec...
Autores principales: | Swanepoel, Conrad C., Loots, Du Toit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977087/ https://www.ncbi.nlm.nih.gov/pubmed/24771957 http://dx.doi.org/10.1155/2014/124218 |
Ejemplares similares
-
Tuberculosis is associated with sputum metabolome variations, irrespective of patient sex or HIV status: an untargeted GCxGC-TOFMS study
por: Beukes, Derylize, et al.
Publicado: (2023) -
Metabolomic applications for understanding complex tripartite plant-microbes interactions: Strategies and perspectives
por: Adeniji, Adetomiwa Ayodele, et al.
Publicado: (2020) -
In Silico Drug Discovery Strategies Identified ADMET Properties of Decoquinate RMB041 and Its Potential Drug Targets against Mycobacterium tuberculosis
por: Knoll, Kirsten E., et al.
Publicado: (2022) -
Elucidating the Antimycobacterial Mechanism of Action of Ciprofloxacin Using Metabolomics
por: Knoll, Kirsten E., et al.
Publicado: (2021) -
Elucidating the Antimycobacterial Mechanism of Action of Decoquinate Derivative RMB041 Using Metabolomics
por: Knoll, Kirsten E., et al.
Publicado: (2021)